Please login to the form below
Evan Lippman joins Aileron Therapeutics
He has experience at EMD Serono, Pfizer and AstraZeneca
Aileron Therapeutics has added to its senior team with the appointment of Evan Lippman as its first chief financial and business officer.
The addition comes as the US biopharma prepares to advance its lead oncology candidate ALRN-6924 into clinical trials.
In Lippman Aileron gains the expertise of a man with great experience in life sciences. Most recently Lippman help a senior VP role at EMD Serono heading the strategy for its US neurology franchise.
Highlights of his career include a spell as executive director at AstraZeneca where he led on huge brands such as Crestor (rosuvastatin calcium) and Nexium (esomeprazole) and heading US business development at the same company.
Lippman's other big pahrma experience includes a period at Pfizer as executive director, worldwide business development and strategic planning.
Featured jobs
-
Account Director - Digital
-
Great salary and benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
-
Scientific Team Lead
-
Competitive Salary
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Scientific Director
-
Highly Competitive Salary &Benefits
-
Associate Medical Director
-
Salary TBC
- Director Healthcare PR Communications
-
Salary TBC
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
-
Account Director
-
Negotiable
- Account Manager, Healthcare Advertising
-
Salary TBC
- Account Director – Global Healthcare PR
-
Salary TBC
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Experienced Editor, London, Medical Communications
-
Competitive package
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
Subscribe to our email news alerts
- Merck & Co picks Nike exec to be digital transformation leader
- Gilead and Aelix join forces to pursue HIV ‘cure’
- Roche preps new Kadcyla filings after phase 3 trial win
- Novartis buys cancer specialist Endocyte for $2.1bn
- Porterhouse Medical rewards superb client service skills
- Retaining reader value in plain language summaries of clinical studies
PMHub
PRMA Consulting Ltd
PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...
Latest intelligence
- Retaining reader value in plain language summaries of clinical studies
- Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
- Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
- Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
- Making Europe a leader in bioscience: boosting trust and opening minds
- A vision of Paris as Europe’s leading hub for life sciences innovation...
Quick links
Infographics
